Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Mid-range Performer

about

Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is a manufacturer and developer of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs). The company focuses on chronic therapeutic areas, including cardiovascular dise...

1044.80 -6.40 (-0.61%)

27.57% Gain from 52W Low

83,169

NSE+BSE Volume

NSE 16 Jun, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

50.4 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

1Yr Price target upside is 18%

Alivus Life Sciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

133 Votes:

Buy 75.19%

Sell 12.03%

Hold 12.78%

×